CTLA4 and non-small cell lung carcinoma: In consideration of the therapeutic significance of treatment approaches related to immune checkpoint blockade in NSCLC, the correlation between the risk score and several immune checkpoints, such as PD1, PDL1, and CTLA4, were analyzed.